Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.

Domino ME, Beadles CA.

Health Serv Outcomes Res Methodol. 2014 Jun 1;14(1-2):34-53.

2.

Managed care and the dissemination of robotic prostatectomy.

Zhang Y, Hollenbeck BK, Schroeck FR, Jacobs BL.

Surg Innov. 2014 Dec;21(6):566-71. doi: 10.1177/1553350614524841. Epub 2014 Jul 21.

3.

How successful is Medicare Advantage?

Newhouse JP, McGuire TG.

Milbank Q. 2014 Jun;92(2):351-94. doi: 10.1111/1468-0009.12061.

4.

Regional variation in acute care length of stay after orthopaedic surgery total joint replacement surgery and hip fracture surgery.

Fitzgerald JD, Weng HH, Soohoo NF, Ettner SL.

J Hosp Adm. 2013;2(4). doi: 10.5430/jha.v2n4p71.

5.

The spillover effects of Medicare managed care: Medicare Advantage and hospital utilization.

Baicker K, Chernew ME, Robbins JA.

J Health Econ. 2013 Dec;32(6):1289-300. doi: 10.1016/j.jhealeco.2013.09.005.

6.

Accountable Care Organizations in the United States: market and demographic factors associated with formation.

Lewis VA, Colla CH, Carluzzo KL, Kler SE, Fisher ES.

Health Serv Res. 2013 Dec;48(6 Pt 1):1840-58. doi: 10.1111/1475-6773.12102. Epub 2013 Oct 1.

7.

Delivery system integration and health care spending and quality for Medicare beneficiaries.

McWilliams JM, Chernew ME, Zaslavsky AM, Hamed P, Landon BE.

JAMA Intern Med. 2013 Aug 12;173(15):1447-56. doi: 10.1001/jamainternmed.2013.6886.

8.

Overuse and systems of care: a systematic review.

Keyhani S, Falk R, Howell EA, Bishop T, Korenstein D.

Med Care. 2013 Jun;51(6):503-8. doi: 10.1097/MLR.0b013e31828dbafe. Review.

9.

Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer.

Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Schroeck FR, Hollenbeck BK.

Urology. 2012 Dec;80(6):1236-42. doi: 10.1016/j.urology.2012.09.006.

10.

The impact of health information technology adoption by outpatient facilities on pregnancy outcomes.

Deily ME, Hu T, Terrizzi S, Chou SY, Meyerhoefer CD.

Health Serv Res. 2013 Feb;48(1):70-94. doi: 10.1111/j.1475-6773.2012.01441.x. Epub 2012 Jun 28.

11.

Pricing of surgeries for colon cancer: patient severity and market factors.

Dor A, Koroukian S, Xu F, Stulberg J, Delaney C, Cooper G.

Cancer. 2012 Dec 1;118(23):5741-8. doi: 10.1002/cncr.27573. Epub 2012 May 8.

12.

Evaluating the medical malpractice system and options for reform.

Kessler DP.

J Econ Perspect. 2011 Spring;25(2):93-110.

13.

The (paper) work of medicine: understanding international medical costs.

Cutler DM, Ly DP.

J Econ Perspect. 2011 Spring;25(2):3-25.

14.

Does managed care affect the diffusion of psychotropic medications?

Domino ME.

Health Econ. 2012 Apr;21(4):428-43. doi: 10.1002/hec.1723. Epub 2011 Mar 7.

15.

Medicare spending and outcomes after postacute care for stroke and hip fracture.

Buntin MB, Colla CH, Deb P, Sood N, Escarce JJ.

Med Care. 2010 Sep;48(9):776-84. doi: 10.1097/MLR.0b013e3181e359df.

16.

Trends in hospital cost and revenue, 1994-2005: how are they related to HMO penetration, concentration, and for-profit ownership?

Shen YC, Wu VY, Melnick G.

Health Serv Res. 2010 Feb;45(1):42-61. doi: 10.1111/j.1475-6773.2009.01047.x. Epub 2009 Oct 13.

17.
18.

Managed care market share and primary treatment for cancer.

Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E.

Health Serv Res. 2006 Feb;41(1):9-22.

19.

Commentary--assessing the impact of managed care patient protection laws: problems and pitfalls.

Hellinger FJ.

Health Serv Res. 2005 Jun;40(3):669-74. No abstract available.

20.

The effect of area HMO market share on cancer screening.

Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D.

Health Serv Res. 2004 Dec;39(6 Pt 1):1751-72.

Items per page

Supplemental Content

Write to the Help Desk